| ||||
Updated RecentlyMacy's Vision Express vs Baxter International Franchise Comparison
Below is an in-depth analysis and side-by-side comparison of Macy's Vision Express vs Baxter International including start-up costs and fees, business experience requirements, training & support and financing options.
Start-Up Costs and Fees |
||
| Investment | $350,000 - $685,000 | $54,450 - $67,450 |
| Franchise Fee | $15,000 | $20,000 |
| Royalty Fee | 7% | 5% |
| Advertising Fee | - | - |
| Year Founded | 1996 | - |
| Year Franchised | 2002 | - |
| Term Of Agreement | 10 years | - |
| Term Of Agreement | 10 years | - |
| Renewal Fee | - | - |
Business Experience Requirements |
||
| Experience | - | - |
Financing Options |
||
| In-House/3rd Party | In-House/3rd Party | |
| Franchise Fees | No/Yes | -/- |
| Start-up Costs | No/Yes | -/- |
| Equipment | No/Yes | -/- |
| Inventory | No/Yes | -/- |
| Receivables | No/Yes | -/- |
| Payroll | No/Yes | -/- |
Training & Support |
||
| Training | Monthly support | - |
| Support | Newsletter, Meetings, Toll-free phone line, Grand opening, Internet, Security/safety procedures, Field operations/evaluations, Purchasing cooperatives | - |
| Marketing | Co-op advertising, Ad slicks, Regional advertising | - |
| Operations |
75% of all franchisees own more than one unit Number of employees needed to run franchised unit: 8 - 15
Absentee ownership of franchise is NOT allowed. (100% of current franchisees are owner/operators) | - |
Expansion Plans |
||
| US Expansion | Yes | - |
| Canada Expansion | No | - |
| International Expansion | No | - |
Company Overviews
About Macy's Vision Express
NO LONGER FRANCHISING
About Baxter International
Baxter gives an expansive arrangement of fundamental renal and clinic items, including home, intense and in-focus dialysis; clean IV arrangements; implantation frameworks and gadgets; parenteral sustenance; biosurgery items and sedatives; and drug store mechanization, programming and administrations. The organization's worldwide impression and the basic way of its items and administrations assume a key part in growing access to medicinal services in rising and created nations. Baxter's representatives worldwide are expanding upon the organization's rich legacy of therapeutic leaps forward to propel the up and coming era of social insurance developments that empower tolerant care.